- China opens $71 bn 'swap facility' to boost markets
- Asian markets track Wall St record as Hong Kong, Shanghai stabilise
- 'Denying my potential': women at Japan's top university call out gender imbalance
- China's central bank says opens up $70.6 bn in liquidity to boost market
- Youth facing unprecedented wave of violence, UN envoy warns
- 'A casino in every kitchen': Brazil's online gambling craze
- Nobel chemistry winner sees engineered proteins solving tough problems
- Discord seen as online home for renegades
- US forecasts severe solar storm starting Thursday
- Ratan Tata: Indian mogul who built a global powerhouse
- One dead as storm Kirk tears through Spain, Portugal, France
- Indian business titan Ratan Tata dead at 86
- Fed minutes highlight divisions over rate cut decision
- Steve McQueen debuts new WWII film at London festival
- Nobel winners hope protein work will spur 'incredible' breakthroughs
- What are proteins again? Nobel-winning chemistry explained
- AI steps into science limelight with Nobel wins
- Overshooting 1.5C risks 'irreversible' climate impact: study
- Demis Hassabis, from chess prodigy to Nobel-winning AI pioneer
- Global stocks diverge as Chinese shares tumble
- Time runs out in Florida to flee Hurricane Milton
- Chad issues warning ahead of more devastating floods
- Creator's death no bar to new 'Dragon Ball' products
- Chinese stocks tumble on lack of fresh stimulus
- Trio wins chemistry Nobel for protein design, prediction
- Braving war: Lebanon's 'badass' airline defies odds
- US weighs Google breakup in landmark trial
- Chinese stocks tumble on stimulus upset, Asia tracks Wall St higher
- 7-Eleven owner confirms new takeover offer from Couche-Tard
- A US climate scientist sees hurricane Helene's devastation firsthand
- Can carbon credits help close coal plants?
- Boeing suspends negotiations with striking workers
- 7-Eleven owner's shares spike on report of new buyout offer
- Your 'local everything': what 7-Eleven buyout battle means for Japan
- AI-aided research, new materials eyed for Nobel Chemistry Prize
- The US economy is solid: Why are voters gloomy?
- Scientists sound AI alarm after winning physics Nobel
- Nobel-winning physicist 'unnerved' by AI technology he helped create
- Trump secretly sent Covid tests to Putin: Bob Woodward book
- Neural networks, machine learning? Nobel-winning AI science explained
- Boeing delivers 27 MAX jets in September despite strike
- Stock markets diverge as Hong Kong sinks, oil prices fall
- US trade gap narrowest in five months as imports slip
- Stay and 'you are going to die': Florida braces for next hurricane
- Geoffrey Hinton, soft-spoken godfather of AI
- Duo wins Physics Nobel for 'foundational' AI breakthroughs
- German 'Maddie' suspect could be free in 2025 after cleared of separate sex crimes
- China slaps provisional tariffs on EU brandy imports
- Duo wins Physics Nobel for key breakthroughs in AI
- German 'Maddie' suspect could be free soon after cleared of separate sex crimes
Philips cuts 6,000 jobs after sleep device recall
Embattled Dutch medical tech maker Philips said on Monday it will slash 6,000 more jobs worldwide in a bid to restore profitability after a massive recall of faulty sleep respirators.
The Amsterdam-based firm revealed the "difficult but necessary" job cuts as it announced losses of 1.6 billion euros ($1.7 billion) in 2022, largely on the back of the safety issue.
The fresh layoffs come just months after Philips announced the loss of another 4,000 posts, against a total workforce of just under 80,000 employees around the globe.
Philips is now facing investigations and lawsuits in the United States after it was forced to recall appliances to treat people with sleep problems that put people at risk of inhaling toxic foam.
Chief Executive Roy Jakobs, who took over in October, said Philips had no choice but to make the "difficult, but necessary further reduction of our workforce by around 6,000 roles globally by 2025."
"2022 has been a very difficult year for Philips and our stakeholders, and we are taking firm actions to improve our execution and step up performance with urgency," Jakobs said in a statement.
Half of the jobs will be cut in 2023.
Philips unveiled net losses of 105 million euros ($114 million) for the fourth quarter of 2022 and 1.6 billion euros for last year as a whole.
- 'Serious' challenges -
Starting off as a lighting company more than 130 years ago, Philips has undergone major changes in recent years, selling off assets to focus on making high-end electronic healthcare products, often for use remotely.
But that shift has been called into question by the giant recall that has pushed it into loss and seen the previous CEO Frans van Houten step down.
Philips announced the global recall in 2021 of its appliances to help people suffering from sleep apnoea, a disorder in which breathing stops and starts when people sleep.
The company said sound-degrading foam in the machines could degrade, causing people to inhale or swallow pieces of the foam with "possible toxic and carcinogenic effects".
Asked if Philips faced an existential risk from the issue, Jakobs acknowledged the firm faced "serious" challenges.
"What we present today is a very strong plan to secure the future of Philips," Jakobs said in a call with reporters.
"Yes, the challenges we have are serious, and we are addressing them head-on."
Philips would focus in particular on product innovation, and on dealing with supply chain issues that were holding up its ability to fulfil its order book, Jakobs said.
The firm needed to "improve performance and simplify our way of working to improve our agility and productivity," he said.
- US probe -
But Jakobs said Philips would also focus on "strengthening our patient safety and quality management" and completing the respirator recall.
The firm has produced around 90 percent of the replacement devices it needs to shop to patients, the company said.
However, it is also increasing the number of replacements, requiring the company to set aside a further 85 million euros.
The company is now under investigation by the US Department of Justice over the respirator issue and is negotiating with US authorities over a financial settlement.
Philips is also the defendant in several class-action lawsuits in the US.
The firm said it had not yet included possible US payouts in its accounts due to the "uncertain nature" of the eventual amounts.
In December, Jakobs told AFP that testing on the recalled respirators showed they were "within safety limits" for use but that a final verdict rested with global regulatory authorities.
Ng.A.Adebayo--CPN